製藥和生物技術領域的合資交易：2016-2026 年

製藥和生物技術領域的合資交易

了解製藥和生物技術公司如何透過合資企業整合能力、共享投資並尋求新的開發和商業化機會。

本報告提供了有關製藥和生物技術領域宣布的458 項合資交易的全面資訊。

本報告分析了公司如何透過合資企業結合互補的資產、技術、專業知識、資本和商業化能力，並檢驗了合作夥伴如何分擔開發新業務機會相關的風險和責任。

本報告不僅列出了交易，還深入分析了哪些公司建立合資企業，它們在哪些地區和行業開展業務，合資企業的結構如何，以及可以從關鍵交易和公開合約中學到什麼。

本報告為評估合資機會或探索替代合作結構的業務發展、公司策略、許可、法律和管理團隊提供了實用的資訊來源和基準。

了解合資交易的全貌

本報告詳細分析了2016年至2026年的合資企業活動，包括以下內容：

• 合資交易的年度趨勢
• 合作關係建立時的發展階段
• 產業部門
• 治療區域
• 技術類型
• 最積極參與合資交易的公司
• 根據已揭露的交易金額，主要交易金額
• 成立合資企業的策略原因
• 生命科學領域合作中合資角色的轉變
• 能夠確定活動集中的領域，了解合資企業在整個行業中的應用情況，並評估積極使用這種合作模式的公司。
• 分析合資企業的結構
• 合資企業與傳統的授權合約或聯合研究協議有著根本的不同，因為合作公司會圍繞特定的商業機會建立一個聯合營業單位或營運結構。

本報告分析了合資協議的結構，並提供了案例研究，可在考慮以下事項時作為參考。

• 所有權和權益比率
• 合夥人的投資狀況
• 資金和投資義務
• 管治與決策
• 管理職責
• 智慧財產
• 負責開發和商業化
• 區域和市場特定權利
• 合約期限和終止條款
• 如已揭露財務安排，則需揭露。
• 這些可以為公司評估合資企業是否是合適的合作模式以及為與潛在合作夥伴進行討論做好準備提供有用的參考點。
• 主要公司的關鍵交易和基準分析
• 本報告根據已揭露的交易金額確定了主要的合資交易，並列出了 25 家最積極參與合資企業的公司的簡介。
• 本報告將幫助了解哪些公司繼續利用合資企業，哪些類型的商業機會促成了這種合作關係，以及每家公司如何在更廣泛的合作策略中定位合資企業。
• 本報告將幫助進行競爭分析、識別潛在合作夥伴以及評估類似和領先的交易。
• 從實際合約文件中學習
• 如果公開，本報告還會提供原始合資協議的查閱途徑。
• 這些協議揭示了僅憑公司公告無法獲得的詳細資訊，使用戶能夠檢驗特定合資企業中所有權、管治、資金籌措、知識產權、責任、終止和其他可協商事項的處理方式。
• 對於考慮或洽談合資企業的公司而言，這些實際合約是了解類似交易在實踐中如何記錄的有用資訊來源。
• 綜合合資交易目錄
• 本報告包含 458 項合資交易的綜合目錄，方便識別和調查與貴公司需求相關的交易。

目錄

執行摘要

第1章 引言

第2章 合資交易趨勢

• 合資交易的定義
• 合資交易趨勢：自2016年以來
  • 合資交易：依年份
  • 合資交易：依發展階段分類
  • 合資交易：依行業分類
  • 合資交易：依治療領域分類
  • 合資交易：依技術類型分類
  • 合資交易：公司中最活躍的合資企業交易
• 參與包括合資企業的合作交易的原因；合資交易的未來。

第3章 合資交易的結構：概述

• 合資交易的結構

第4章 重大合資交易

• 主要合資交易：依交易金額

第5章 參與合資交易最活躍的25家公司

• 參與合資交易最活躍的前25家公司

第6章 合資交易目錄（含合約）

• 合資交易中，合約可以審查
• 交易目錄
• 交易目錄：依公司名稱（A-Z）
• 交易目錄：依治療領域
• 交易目錄：依技術類型
• 關於生物製藥研究
• Current Partnering
• Current Agreements
• Current Partnering近期報告標題

Joint Venture Deals in Pharmaceuticals and Biotechnology

Understand how pharmaceutical and biotechnology companies use joint ventures to combine capabilities, share investment and pursue new development and commercial opportunities.

Joint Venture Deals in Pharmaceuticals and Biotechnology provides comprehensive intelligence on 458 joint venture deals announced across the pharmaceutical and biotechnology sectors.

The report examines how companies are using joint ventures to bring together complementary assets, technologies, expertise, funding and commercial capabilities while sharing the risks and responsibilities associated with developing new opportunities.

Rather than simply identifying transactions, the report enables users to understand who is forming joint ventures, where activity is taking place, how joint ventures are structured, and what can be learned from leading transactions and publicly available contract documents.

It provides a practical intelligence and benchmarking resource for business development, corporate strategy, licensing, legal and senior management teams evaluating joint venture opportunities or considering alternative partnering structures.

Understand the joint venture deal landscape

The report provides detailed analysis of joint venture activity from 2016 to 2026, including:

• Joint venture dealmaking trends by year
• Stage of development at the time of partnering
• Industry sector
• Therapy area
• Technology type
• Most active joint venture dealmakers
• Leading deals by disclosed value
• Strategic reasons for entering joint ventures
• The evolving role of joint ventures within life sciences partnering
• This enables users to identify areas of concentrated activity, understand how joint ventures are being applied across the industry and assess the companies most actively using this form of partnership.
• Examine how joint ventures are structured
• Joint ventures differ fundamentally from conventional licensing and collaboration agreements because the partners establish a shared business or operating structure around a defined opportunity.

The report examines the structure of joint venture agreements and provides real-world examples that can help users consider areas including:

• Ownership and equity participation
• Partner contributions
• Funding and investment commitments
• Governance and decision-making
• Management responsibilities
• Intellectual property rights
• Development and commercialization responsibilities
• Geographic and market rights
• Term and termination provisions
• Financial arrangements where disclosed
• This provides useful reference points for companies assessing whether a joint venture is an appropriate partnering model and preparing for discussions with prospective partners.
• Benchmark leading transactions and dealmakers
• The report identifies leading joint venture transactions by disclosed deal value and profiles the Top 25 most active joint venture dealmakers.
• Users can examine which companies are repeatedly using joint ventures, the types of opportunities attracting these partnerships and how individual companies are applying the model within their wider partnering strategies.
• This can support competitor analysis, partner identification and the assessment of precedent transactions.
• Learn from real-world contract documents
• Where publicly available, the report provides access to underlying joint venture contract documents.
• These agreements can reveal significantly more detail than company announcements alone, enabling users to examine how selected joint ventures address ownership, governance, funding, intellectual property, responsibilities, termination and other negotiated provisions.
• For teams considering or negotiating a joint venture, these real-world agreements provide valuable insight into how comparable transactions have been documented in practice.
• Comprehensive joint venture deal directory
• The report includes a comprehensive directory of 458 joint venture deals, allowing users to identify and investigate transactions relevant to their own requirements.

Deals can be reviewed by:

• Company
• Therapy area
• Technology type
• Contract availability
• Individual transactions are linked to their underlying deal records, providing a route to further deal information and associated contract documentation where available.
• Who should use this report?
• Business Development and Licensing teams
• Evaluate joint venture opportunities, identify active participants and examine comparable transactions.
• Corporate Strategy teams
• Understand how joint ventures are being used to combine capabilities, enter new markets, share investment and pursue strategic opportunities.
• Legal and Transaction teams
• Review agreement structures, governance arrangements and real contract language from relevant transactions.
• Competitive and Market Intelligence teams
• Track joint venture activity by company, therapy area, technology and industry sector.
• Senior Management and Investors
• Assess the strategic rationale, structure and participants behind significant joint venture activity.
• Turn market-wide intelligence into company-specific insight
• For qualifying customers, Current Partnering can also provide a Customized Executive Partnering Briefing alongside the report.
• The briefing applies the underlying deal intelligence to the customer's own business, technologies, assets or strategic objectives.
• Depending on requirements, this can include relevant comparable transactions, potential partners, competitor activity, deal structures, financial benchmarks, contract insights and other intelligence selected specifically for the client's partnering situation.
• Request a sample or contact Current Partnering to discuss the report and whether a customized analysis can be provided for your organization.

Table of Contents

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in joint venture dealmaking

• 2.1. Introduction
• 2.2. Definition of joint venture deal
• 2.3. Trends in joint venture deals since 2016
  • 2.3.1. Joint venture dealmaking by year, 2016-2025
  • 2.3.2. Joint venture dealmaking by phase of development, 2016-2025
  • 2.3.3. Joint venture dealmaking by industry sector, 2016-2025
  • 2.3.4. Joint venture dealmaking by therapy area, 2016-2025
  • 2.3.5. Joint venture dealmaking by technology type, 2016-2025
  • 2.3.6. Joint venture dealmaking by most active company, 2016-2025
• 2.4. Reasons for entering into joint venture partnering deals
• 2.5. The future of joint venture deals

Chapter 3 - Overview of joint venture deal structure

• 3.1. Introduction
• 3.2. Joint venture agreement structure

Chapter 4 - Leading joint venture deals

• 4.1. Introduction
• 4.2. Top joint venture deals by value

Chapter 5 - Top 25 most active joint venture dealmakers

• 5.1. Introduction
• 5.2. Top 25 most active joint venture dealmakers

Chapter 6 - Joint venture deals including contracts directory

• 6.1. Introduction
• 6.2. Joint venture deals with contracts 2016-2025
• Deal directory
• Deal directory - joint venture dealmaking by companies A-Z
• Deal directory - joint venture dealmaking by therapy area
• Deal directory - joint venture dealmaking by technology type
• About Biopharma Research
• Current Partnering
• Current Agreements
• Recent report titles from Current Partnering

TABLE OF FIGURES

• Figure 1: Definition of joint venture deal
• Figure 2: Trends in joint venture deal announcements, 2016-2025
• Figure 3: Joint venture deals signed at each phase of development, 2016-2025
• Figure 4: Joint venture deals by industry sector, 2016-2025
• Figure 5: Joint venture deals by therapy area, 2016-2025
• Figure 6: Joint venture deals by technology type, 2016-2025
• Figure 7: Top 25 most active joint venture dealmakers, 2016-2025
• Figure 8: Top joint venture deals by value, 2016-2025
• Figure 9: Most active joint venture dealmakers, 2016-2025